Real-World Data Insights into Antidepressant Prescription and Adherence During Pregnancy in Catalonia (Spain)

Journal article

Background: Affective disorders, particularly depression, are common among women of childbearing age, and pregnancy often exacerbates symptoms. Antidepressants are often required for treatment, but adherence during pregnancy is variable. Although some studies suggest potential risks to the foetus, many cannot rule out confounding by indication. In this context, understanding real-world patterns of antidepressant prescription and adherence during pregnancy is essential to inform clinical practice and ensure adequate mental healthcare. Objective: The aim of the present study was to characterise the use of antidepressants in a cohort of pregnant women using electronic health records. Methods: This observational cohort drug-utilisation study assessed antidepressant prescription patterns, adherence and persistence among pregnant women using data from the SIDIAP (Information System for the Development of Research in Primary Care) database in Catalonia from January 2011 to June 2020. Results: Among 99,605 pregnancies, 14.9% involved antidepressant prescriptions, but only 5.8% of these were collected from pharmacies. The median pregnancy duration was 38.4 weeks, and the median maternal age was 33.5 years. Anxiety was the most common health issue associated with an antidepressant prescription. Paroxetine was the most frequently prescribed antidepressant, although sertraline usage increased over time. Antidepressant prescriptions and adherence decreased during pregnancy, with an increase in the postpartum period. About 11.6% of pregnancies involved a concurrent prescription of another antidepressant, and 29.2% of women resumed antidepressant use after pregnancy. Women who initiated antidepressants during pregnancy were more likely to persist with treatment than those with pre-existing prescriptions. Conclusions: Our study describes antidepressant use during pregnancy in Catalonia. It is remarkable that there is a notable gap between antidepressant prescriptions and dispensations. Given the risks of untreated maternal depression, strengthening primary care with adequate resources and personalised support is essential for improving perinatal mental healthcare.

Authors: Bellas, L; Camacho-Arteaga, L; Giner-Soriano, M; Albert-Prats-Uribe; Gómez-Lumbreras, A

• Alternative title: Real-World Data Insights into Antidepressant Prescription and Adherence During Pregnancy
• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Springer
• Journal: Drug Safety: The Official Journal of the International Society of Pharmacovigilance
• Volume: 48
• Issue: 12
• Pages: 1353-1364
• Publication date: 2025-07-09
• Acceptance date: 2025-06-12
• DOI: 10.1007/s40264-025-01576-z
• EISSN: 1179-1942
• ISSN: 0114-5916
• Language: English
• Keywords: Medicine; Medical prescription; Pregnancy; Antidepressant; Context (archaeology); Psychiatry; Sertraline; Pharmacoepidemiology; Depression (economics); Cohort study; Confounding; Observational study; Anxiety; Obstetrics; Pediatrics; Internal medicine; Pharmacology